Lumos Pharma Receives $14,000,000 Series A Funding

  • Feed Type
  • Date
    2/6/2014
  • Company Name
    Lumos Pharma
  • Mailing Address
    Undisclosed Austin, TX 78701
  • Company Description
    Lumos Pharma, based in Austin, Texas, is an early stage biotechnology company created to develop and commercialize a novel treatment for the rare disease Creatine Transporter Deficiency.
  • Website
    http://www.lumos-pharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Lumos Pharma will use the financing to support the preclinical and clinical development of its lead compound, LUM-001.
  • M&A Terms
  • Venture Investor
    Sante Ventures
  • Venture Investor
    New Enterprise Associates

By posting a comment, you agree to our terms and conditions.